Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
Viruses · 2024
DOI: 10.3390/v16060863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Jordan J Clark und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF,…. Hauptthemen laut MEDLINE: COVID-19, Disease Models, Animal, SARS-CoV-2, Influenza A virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Food and Drug Administration, Biotechnology and Biological Sciences Research Council, Medical Research Council.
Abstract (Originalsprache)
COVID-19 is a spectrum of clinical symptoms in humans caused by infection with SARS-CoV-2. The coalescence of SARS-CoV-2 with seasonal respiratory viruses, particularly influenza viruses, is a global health concern. To understand this, transgenic mice expressing the human ACE2 receptor (K18-hACE2) were infected with influenza A virus (IAV) followed by SARS-CoV-2 and the host response and effect on virus biology was compared to K18-hACE2 mice infected with IAV or SARS-CoV-2 alone. The sequentially infected mice showed reduced SARS-CoV-2 RNA synthesis, yet exhibited more rapid weight loss, more severe lung damage and a prolongation of the innate response compared to the singly infected or control mice. Sequential infection also exacerbated the extrapulmonary encephalitic manifestations associated with SARS-CoV-2 infection. Conversely, prior infection with a commercially available, multivalent live-attenuated influenza vaccine (Fluenz Tetra) elicited the same reduction in SARS-CoV-2 RNA synthesis, albeit without the associated increase in disease severity. This suggests that the innate immune response stimulated by IAV inhibits SARS-CoV-2. Interestingly, infection with an attenuated, apathogenic influenza vaccine does not result in an aberrant immune response and enhanced disease severity. Taken together, the data suggest coinfection (‘twinfection’) is deleterious and mitigation steps should be instituted as part of the comprehensive public health and management strategy of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
- Department of Tropical Disease Biology, Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
- School of Cellular and Molecular Medicine, Faculty of Life Sciences, University of Bristol, Bristol BS8 1QU, UK.
- Department of Clinical Infection Microbiology and Immunology and NIHR Health Protection Research Unit for Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liver…
- Tropical & Infectious Disease Unit, Royal Liverpool University Hospital, Liverpool L7 8YE, UK.
- Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
ORCID-Profile: Rebekah Penrice-Randal, Parul Sharma, Shaun H Pennington, David A Matthews, Lance Turtle, Grant L Hughes, Edward I Patterson, Jo Sharp, Giancarlo A Biagini, Andrew Owen, Anja Kipar, Julian A Hiscox, James P Stewart
Förderung
- United States Food and Drug Administration
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- Wellcome Trust
- US Food and Drug Administration Grant
- MRC Discovery Medicine North (DiMeN) Doctoral Training Partnership
- UK Research and Innovation Strength in Places Fund
- Welcome Trust
Zitieren
APA
Clark, J. J., Penrice-Randal, R., Sharma, P., Dong, X., Pennington, S. H., Marriott, A. E., Colombo, S., Davidson, A., Kavanagh Williamson, M., Matthews, D. A., Turtle, L., Prince, T., Hughes, G. L., Patterson, E. I., Shawli, G., Mega, D. F., Subramaniam, K., Sharp, J., Turner, J. D., …, & Stewart, J. P. (2024). Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19. Viruses. https://doi.org/10.3390/v16060863
Vancouver
Clark JJ, Penrice-Randal R, Sharma P, Dong X, Pennington SH, Marriott AE, et al. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19. Viruses. 2024. doi:10.3390/v16060863
BibTeX
@article{Clark2024,
author = {Clark, Jordan J and Penrice-Randal, Rebekah and Sharma, Parul and Dong, Xiaofeng and Pennington, Shaun H and Marriott, Amy E and Colombo, Stefano and Davidson, Andrew and Kavanagh Williamson, Maia and Matthews, David A and Turtle, Lance and Prince, Tessa and Hughes, Grant L and Patterson, Edward I and Shawli, Ghada and Mega, Daniele F and Subramaniam, Krishanthi and Sharp, Jo and Turner, Joseph D and Biagini, Giancarlo A and Owen, Andrew and Kipar, Anja and Hiscox, Julian A and Stewart, James P},
title = {Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060863}
}
EUVIMED